William D. Johnston
Director/Board Member at Biotechnology Innovation Organization
Profile
William D.
Johnston is currently a Director at Biotechnology Innovation Organization and a Director at Center for Global Health Innovation, Inc. He was previously the Chief Executive Officer at InVasc Therapeutics, Inc. and a Director at Inhibitex LLC.
Prior to that, he was the Vice President & GM-Gene Therapy Business Unit at Baxter Healthcare Corp.
He received his undergraduate and doctorate degrees from Brigham Young University.
William D. Johnston active positions
Companies | Position | Start |
---|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Center for Global Health Innovation, Inc.
Center for Global Health Innovation, Inc. BiotechnologyHealth Technology Center for Global Health Innovation, Inc. is a member of Georgia Bio, a non-profit life sciences association in Georgia. The non-profit company is based in Atlanta, GA. Georgia Bio works with various organizations to shape public policy, improve access to innovative technologies, and grow Georgia's life sciences economy. The CEO of the company is Maria Thacker-Goethe. | Director/Board Member | 31/12/1998 |
Former positions of William D. Johnston
Companies | Position | End |
---|---|---|
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Director/Board Member | 18/09/2000 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 31/12/1996 |
InVasc Therapeutics, Inc.
InVasc Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology InVasc Therapeutics, Inc. engages in the development of drugs for treating and preventing cardio metabolic disease. It specializes in target-specific drug discovery with several potential drug therapies at the pre-clinical stage. The company was founded in 2006 and is headquartered in Tucker, GA. | Chief Executive Officer | - |
Training of William D. Johnston
Brigham Young University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
InVasc Therapeutics, Inc.
InVasc Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology InVasc Therapeutics, Inc. engages in the development of drugs for treating and preventing cardio metabolic disease. It specializes in target-specific drug discovery with several potential drug therapies at the pre-clinical stage. The company was founded in 2006 and is headquartered in Tucker, GA. | Health Technology |
Center for Global Health Innovation, Inc.
Center for Global Health Innovation, Inc. BiotechnologyHealth Technology Center for Global Health Innovation, Inc. is a member of Georgia Bio, a non-profit life sciences association in Georgia. The non-profit company is based in Atlanta, GA. Georgia Bio works with various organizations to shape public policy, improve access to innovative technologies, and grow Georgia's life sciences economy. The CEO of the company is Maria Thacker-Goethe. | Health Technology |
- Stock Market
- Insiders
- William D. Johnston